House of Commons photo

Crucial Fact

  • Her favourite word was health.

Last in Parliament October 2015, as Conservative MP for Sarnia—Lambton (Ontario)

Won her last election, in 2011, with 53% of the vote.

Statements in the House

Food and Drugs Act May 31st, 2012

Mr. Speaker, it is a pleasure to stand here this evening as we go through the final second hour of third reading of my private member's Bill C-313.

This has been a fairly long process. It started back in 2007 with the introduction of my private member's motion, which as the member across has alluded to, was passed unanimously but then died on the order paper. It is greatly gratifying to see that the bill has reached this stage.

I want to thank the members who have spoken not only tonight in favour of this bill but all the way through this process. Whether it was through second reading or whether it was at committee stage, there has been wonderful support for the bill. All members and all parties have shown support, and I thank them for that.

There has been support through two ministers of health, as well, and Health Canada. The bill has been very well supported.

The industry has been 100% supportive. I have received a great deal of assistance from it in getting the correct medical facts. I have received wonderful support from everybody involved.

We know that this bill would help improve and protect the eye health of Canadians, as has been said in many cases, affecting our young people more than others.

I am pleased to see the bill at this stage. I look forward to its being passed through the House and sent on to the other place.

Medical Imaging Team Day May 17th, 2012

Mr. Speaker, as a former medical radiation technologist, I am honoured to stand before members today and call attention to the inaugural Medical Imaging Team Day event taking place on Parliament Hill. Medical Imaging Team Day has been established to recognize the contribution that the imaging team, comprised of physicians, physicists, sonographers and technologists, makes to the Canadian health care system.

Today I salute the following groups that are taking part in Medical Imaging Team Day: the Canadian Association of Medical Radiation Technologists, the Canadian Association of Nuclear Medicine, the Canadian Association of Radiologists, the Canadian Interventional Radiology Association, the Canadian Organization of Medical Physicists and the Canadian Society of Diagnostic Medical Sonographers. I thank these groups for their vital contributions to Canadian health care.

Natural Resources April 24th, 2012

Mr. Speaker, there is currently a proposal to restore a flow of oil to its original direction from west to east, from Alberta to Ontario. This is a routine proceeding requiring little change.

This proposal would reduce our dependence on foreign oil, create jobs and help consumers. This is a win-win for everyone across the country and could create much-needed economic opportunities in my riding of Sarnia—Lambton. However, there are those who seek to delay this process. Could the Minister of Natural Resources update the House?

Food and Drugs Act April 4th, 2012

Madam Speaker, I very much appreciated support the member opposite afforded me when I appeared before the health committee. There were some very good questions that arose at committee. The member, who is well aware of the issues, asked some very pertinent questions.

As I said in my speech, I have been bringing this issue forward since 2007. Right from the very onset, I have had the full support of Health Canada, plus the ministers of health, and there has been more than one minister during that time.

This issue is being supported. I have been encouraged by Health Canada and the ministers of health to continue forward with this. It was an issue that would have been included in government legislation when I put forward my private member's motion. Unfortunately, because of elections, Bill C-51 died on the order paper. Other than that, this would have appeared in government legislation.

It was brought forward, on my initiative, as a stand-alone private member's bill following that because I had done so much work and research on it and I wanted to see the issue moved forward quickly.

Food and Drugs Act April 4th, 2012

moved that the bill be read the third time and passed.

Mr. Speaker, it is an honour to stand among my fellow parliamentarians today as I speak in support of my private member's legislation advancing to third reading.

Bill C-313, an act to amend the Food and Drugs Act (non-corrective contact lenses), has received unanimous all-party support at every level of debate since its introduction in the House. Even at the committee review stage, all parliamentarians from the various parties have expressed their full support.

In the few months since my legislation was first introduced, there have been millions of non-corrective contact lenses recalled across the North American marketplace for quality control issues. Such stories have become more common, and Canadians are just beginning to open their eyes to the importance of their eye health. As we shed more light on this issue, we will continue to hear about such product recalls in the news. That is why Bill C-313 is supported across party lines and by virtually all Canadian eye health professionals. Canadian policy-makers are keenly aware of the impact my legislation would have across Canada, just as many of my colleagues have followed my legislation's progress.

Organizations like the Canadian Association of Optometrists have been key players in helping to spread the word on this important consumer health issue. The Canadian Association of Optometrists, the Opticians Association of Canada and the Canadian Ophthalmological Society have all come out in support of this legislation, and many more provincial bodies and their representatives have voiced their support as well. I will share some of their opinions with the House in due course.

I would like to thank the individual optometrists and ophthalmologists who have taken time from their busy practices right across Canada to write to me to voice their support. I realize that many of these same professionals took the time to write to their own MPs, asking them to support this private member's business, and for this I am grateful.

As we discuss the bill now at third reading, I intend to share medical evidence with the House that will provide clear reasons why we need my legislation. However, before we discuss Bill C-313 further, I want to take members back to the autumn of 2007 in the 39th Parliament of Canada.

One of my first responsibilities as a new member of Parliament was to be a member of the Standing Committee on Health. Looking back at my time on that specific committee, I was particularly seized by the concerns that were brought to me by professional eye care organizations from across Canada about the lack of regulatory oversight of what were called cosmetic contact lenses.

It is easy to break down the main concern brought forward to me all those years ago. A cosmetic contact lens is identical to a corrective lens in its impact on the human eyeball, with the only difference being that it does not correct a sight imbalance. However, despite the fact they are identical to a corrective lens, these cosmetic lenses have been free of regulatory oversight similar to the provisions in place for corrective lenses. It was with this in mind that I began to work in 2007 to further understand the risks of cosmetic contact lenses.

After extensive study, liaising with health researchers and eye care professions and meeting with our own experts from Health Canada and engaging with the opposition health critics, I developed a strategy that would go further toward protecting the eye health of Canadians everywhere. The result was private member's Motion No. 409, which proposed that cosmetic lenses should be classified as medical devices and be regulated accordingly under the Food and Drugs Act. The actual text of Motion No. 409 read as follows:

That, in the opinion of the House, the Minister of Health should regulate non-corrective, cosmetic contact lenses as medical devices under the Hazardous Product Act or the Food and Drugs Act.

This motion passed unanimously on March 7, 2008, in a fractured minority Parliament no less, which I believe is testament to the fact we are discussing an important health matter that could impact many Canadians, especially our youth. When faced with the facts on non-corrective contact lenses in 2008, we as a Parliament did the right thing by supporting Motion No. 409 and we stand to do so again with Bill C-313.

I was pleased that the government acted upon the unanimously passed motion. It was 2008 when the Government of Canada, upon advice from Health Canada, introduced my motion as an amendment to former Bill C-51, an act to amend the Food and Drugs Act and to make consequential amendments to other acts. That act was introduced in April 2008 but also died on the order paper upon the election in the fall of 2008.

That was unfortunate. Having already used my private member's spot in the 39th Parliament, I found myself near the bottom of a long private members' business list. It can be a long wait before MPs have the opportunity to again bring forward legislative items once they have used their spot on that list.

Moving ahead to late 2010, in the 40th Parliament it became evident that I would be able to bring forward private members' business. Knowing that Canadians still had concerns about the existing policies in Canada surrounding non-corrective cosmetic lenses, I directed my research staff to determine what types of legislative remedies could be brought forward. In short order, they developed opinions to deal with my previously unfinished private members' business as a stand-alone piece of legislation.

More time passed. Subsequently, we had another election and I was re-elected by the good people of Sarnia—Lambton. With the return of the 41st Parliament, my name was near the top of the list for private members' business, meaning that months of research and efforts by my office were about to be realized and we would finally be able to bridge the regulatory gaps that exist for decorative non-corrective lenses.

This legislative process has taken place across three different sessions of Parliament and now stands at third reading before the House of Commons.

With this background on my bill before the House, I would like to speak directly to Bill C-313, An Act to amend the Food and Drugs Act (non-corrective contact lenses).

Eye health professionals have been saying for a long time what we now know to be fact: National distribution of these products without professional oversight, fitting and training significantly increases the risk of public harm. This is the main finding captured by independent research reports. It is what Canadian eye health organizations have found. Now we see peer-reviewed science from reputable academics and institutions across the globe now fully supporting these findings.

To speak to the potential medical issues than can arise from the use of non-corrective contact lenses, stating that a decorative lens is potentially a harmful product may seem to some to be an overstatement, yet medical researchers have shown otherwise.

A list of the complications that could occur due to unsafe handling and the wearing of an improperly fitted lens in one's eye includes the following: conjunctivitis; corneal abrasions; giant papillary conjunctivitis; microbial keratitis; and other forms of bacterial, allergic, and microbial infection, as specified by the eye care industry.

Already, we know that these complications all occur with prescribed corrective lenses, which is exactly why Health Canada regulates the use of these products through opticians and regulatory bodies. Furthermore, it has been proven through peer-reviewed studies that non-corrective lenses are much more likely to cause complications to users because of a combination of factors, including lack of oversight of the product for the consumer, in particular how to use the product and issues with the potential quality of the product.

The Internet market for these products has grown immensely, even since 2006. We are talking about a market share in the millions and tens of millions of dollars. Much of this revenue is taken offshore. We need to ensure that Canadian consumer are protected when it comes to such operations.

To date, we have now seen several studies on the issue of decorative lenses and the harm they can cause to consumers. Perhaps the most well-known study in Canada is the human health risk assessment of cosmetic contact lenses conducted by Dillon Consulting Limited. Also known as the Dillon report, the final assessment was submitted to Health Canada in September of 2003 and outlined the scientific evidence, which at that point was still being debated by public health officials, namely that the level of risk associated with the use of cosmetic contact lenses is comparable to that associated with corrective lenses, and may potentially be higher. The main issue here is that corrective lenses are subject to professional monitoring and proper regulatory oversight. Cosmetic lenses are not.

The Dillon report also called for the following risk management strategies: individual screening should take place before a cosmetic lens is sold to a customer; proper fitting should be ensured; adequate instruction on cleaning and sterilization should occur; and consumers should be made familiar with potential symptoms related to the condition of the eye; and regular aftercare is needed.

To date, not one of the suggested risk management strategies called for in this report has been adopted, while corrective lenses are strictly defined by Health Canada. My legislation would address this problem.

Whereas the long list of issues associated with non-corrective contact lens use was once viewed somewhat contentiously by policy-makers, such health concerns are now considered an accepted fact of non-corrective contact lens use, due to a recent study that appeared in Acta Ophthalmologica, the official medical journal for optometrists and ophthalmologists in Europe. In this study, research conducted by the department of opthalmology at Strasbourg University Hospital in France clearly indicated the following:

Patients who acquire CosCL [cosmetic contact lenses] are less likely to be instructed on appropriate lenses use and basic hygiene rules. Consequently, CosCL wearers are experiencing acute vision-threatening infections.

The study in question focused on a bacterial infection known as microbial keratitis, a common yet preventable infection that can occur in wearers of contact lenses, both the corrective and non-corrective, cosmetic varieties. This study showed that wearers of cosmetic lenses were indeed at higher risk, with 79% of the control group of cosmetic contact lens wearers suffering from corneal scraping. However, the study showed that only 51% of the corrective contact lens wearers suffered similar effects. Meanwhile, more than half of the cosmetic lens wearers who were shown to have suffered corneal scraping were also shown to have serious microbial infection in the eye.

The study concluded that the increasingly documented risks of easily accessible cosmetic contact lenses were a serious concern in the country of France, where the study took place. In this regard, there is no reason to believe that the situation is any different in Canada, and in fact the Dillon report of 2003, which in many ways served as a ground-breaker on this issue, also came to the same conclusions as the French study in 2011.

Considering the medical evidence that clearly shows the need for the provisions contained in Bill C-313, it is important to note that Canada is at least a decade behind other jurisdictions, such as the United States and Europe, in achieving proper regulations for non-corrective cosmetic lenses.

In 2008, M-409 was able to obtain the full support of all opposition parties and their health critics, in addition to the support of the government and the Minister of Health.

Today, with Bill C-313, I ask hon. members to stand with me once again as we deal with this important issue. Listen to what some of our leading eye care experts from across Canada have had to say about this piece of legislation.

An optometrist from Newfoundland has stated, “In my province there are novelty shops and drugstores that are selling these lenses without regard for the possible health implications to eyesight. All our opticians want to stop this activity of unregulated dispensing”. Moreover, Clearlycontacts.ca, a Canadian ebusiness provider of vision-care products, has also stated on the record that, “At Clearlycontacts, we support regulatory oversight in the sale of non-corrective contact lenses and fully support Bill C-313”.

Dana Cooper of the Canadian Association of Optometrists has said that:

Bill C-313 is a commonsense initiative that aligns all contact lenses in the same federal regulatory environment. Bill C-313 makes sense from a vision health perspective, a consumer protection perspective, and is justified based on the concerns and actions already taken and being pursued by governments around the world.

In addition, I have also received strong endorsements from the Opticians of Manitoba, the Saskatchewan College of Opticians and also the School of Optometry and Vision Science in Waterloo, Ontario.

Internationally, Bill C-313 has the support of esteemed groups, such as the Contact Lens Institute of Florida and the American Optometric Association of Virginia.

The need for this legislation has never been greater than it is today. The Internet marketplace has opened doors for international buyers and sellers of these products like never before, and as policy-makers we have a duty to ensure that the eye health of Canadian consumers is protected as much as possible.

I believe that Bill C-313 is the first step in this direction, and today I call on all esteemed members of this House to stand in support of my private member's legislation.

Food and Drugs Act April 4th, 2012

moved that the bill, as amended, be concurred in.

Bioindustrial Innovation Centre March 27th, 2012

Mr. Speaker, today I speak in support of my community of Sarnia—Lambton where we have focused on expanding our economy to unleash the knowledge of our local workforce. This means we have had to find innovative projects for our community.

The Government of Canada has assisted in this effort with an investment of $15 million under the national centres of excellence program, seed money that helped create the Bioindustrial Innovation Centre.

This week we are seeing a world leading effort in action as the Bioindustrial Innovation Centre hosts the BIC international conference to discuss the risks to commercialization of biochemicals and bioproducts.

Sarnia's economic stakeholders are attempting to link our industrial know-how with opportunities connected to the Alberta oil sands. We have the skilled labour and the fabrication capabilities to play a vital role in this capacity.

It is time for stakeholders in Ontario to realize the full potential there is for co-operation with our friends in the Alberta energy sector.

Federal Framework For Suicide Prevention Act February 9th, 2012

Mr. Speaker, I thank the House for the opportunity to continue my earlier remarks on this matter first delivered in support of the private member's legislation that was introduced by my hon. colleague from Kitchener—Conestoga in October 2011.

Bill C-300 is extremely important and I would like to share with the House several personal experiences I have had over the last few months, which have assisted me in developing a stronger appreciation for the work done by professionals in communities all across Canada in regard to mental health and specifically suicide prevention.

As some of my colleagues here in the House know, my community of Sarnia—Lambton was rocked by a series of youth suicides in a short period of time in the recent past.

Stakeholders, particularly those on the front lines of the mental health community, were doing everything in their power to assist families in my riding that had been hurt by youth suicide, while at the same time providing preventative services to youth who were depressed and possibly having suicidal thoughts.

With this in mind, I began organizing a one day symposium for my community to address these serious issues.

From the beginning, the Mental Health Commission of Canada played an integral role in working with my office to bring the issue of youth suicide and mental health to the forefront in my own community.

This idea grew into the Sarnia—Lambton symposium on youth mental health, which I was able to host in my riding at Lambton College that provided logistical support.

In addition, I worked with a myriad of community mental health stakeholders from Sarnia—Lambton, including Joanne Klauke-LaBelle from Harmony for Youth, Sharon Berry Ross from the Sarnia—Lambton Suicide Prevention Committee and also Ruth Geurts, a prominent faculty member within the social work program at Lambton College.

I would also like to thank Aaron Levo and Claire Checkland from the Mental Health Commission of Canada for their outstanding contributions to the symposium as well.

There were many others who attended and participated in the event, including special invitees who were considered regional stakeholders, such as local mayors, education directors from school boards and also my colleague, the member for Kitchener—Conestoga, who was able to attend for the full day and speak in support of his Bill C-300 at the symposium. We were also thankful to have a keynote address from Dr. David Goldbloom, who appeared courtesy of the Mental Health Commission of Canada.

Dr. Goldbloom is the senior medical advisor at the Centre for Addiction and Mental Health and a professor of psychiatry at the U of T. He is one of Canada's greatest minds on the issue of youth mental health.

The Sarnia—Lambton symposium on youth mental health was an effort on my behalf to raise the issues of youth suicide in a proactive forum of mental health stakeholders from across various levels of government so we could discuss the benefits and pitfalls of the existing framework in Canada across provincial lines.

I heard an array of stories that pointed out areas where we as policy makers could make direct improvements. I also heard that there was a strong willingness from all levels of government to do their best to ensure we were implementing policies that would help our youth in communities that were having issues with depression and other forms of mental illness.

With this in mind, I strongly support my colleague's efforts to further assist in this regard, which will be accomplished by the measures contained in Bill C-300.

Although Canada has made several important investments under the current government for mental health, including the formation of the Mental Health Commission of Canada and long-term funding for this organization, we have much work to do to address the severity of the issue of youth suicide. I realize it is now an issue we are all seized with as policy-makers, as youth suicide occurs in every community across Canada and is the second leading cause of death among our youth aged 10 to 24.

It is extremely upsetting to think of the bright lights of our youth being faced with such inner turmoil that they would choose to end their own life. However, in Canada it is an alarming issue that we must work together to address immediately.

In addition to events like the Sarnia—Lambton symposium on youth mental health, it is good to see corporations like Bell coming forward with innovative ideas such as the Let's Talk campaign that began this week.

I would even like to commend our hon. colleague, the member for Toronto Centre, who has shared his own battles with depression with Canadians in a very public manner. It takes a great deal of courage to share such personal stories and actions such as this can and will have a positive impact on the overall discussion toward mental health and specifically youth suicide prevention.

As we continue to place these issues on the forefront of Canadian discourse, I believe we will see more Canadians taking action to ensure that we enable discussions on mental health issues rather than treating the issue with stigma. Although it is good to see youth suicide prevention being discussed more openly in our society, the reality is it is still an urgent matter.

Regrettably, the day following the symposium in my community a youth tragically took his life. This pointed out to me the fragile nature of the youth we were attempting to reach out to and it really hit home how severe the issue had become across all of our communities. Therefore, we need to back the talk up with actions and it is my belief that Bill C-300 would build upon other actions already taken by this government, such as the formation of the Mental Health Commission of Canada, so we can truly make a difference on this issue.

I understand the commission will be releasing a report this year and I greatly look forward to reviewing it when it becomes available. Furthermore, I support the efforts of our Minister of Health who has had the opportunity to raise the issue of suicide prevention with provincial health ministers.

The efforts taken by those like my humble colleague from Kitchener—Conestoga can help shine like a beacon in the darkness and it is my sincere hope that members in the House will join together to support this important legislation fully and completely. Our youth are depending on us to do so.

National Defence February 9th, 2012

Mr. Speaker, Canadians gave us a strong mandate to protect law-abiding Canadians from those who wish to harm us. Canada is not immune from the threats of radical-led terrorism. Far too often, we see cases where those who would seek to destroy our way of life are plotting to harm us.

Could the Minister of National Defence please tell us what the government is doing to protect us?

Food and Drugs Act January 31st, 2012

Madam Speaker, I would like to take this opportunity to thank all parliamentarians who spoke in the House of Commons for their support of Bill C-313. I believe this legislation would strengthen consumer protection measures for Canadians and would serve to address the concerns raised with me by Canadian eye care professionals.

I also thank the House of Commons private members' business office and also legal services for their excellent work leading up to the introduction of Bill C-313. All of their work behind the scenes for MPs' legislative business is greatly appreciated.

In addition to my parliamentary colleagues, I thank the many professionals within the eye care community who have supported my private member's bill. In fact, members of the eye care community have been calling for the regulatory changes contained in my PMB for over a decade now. Bill C-313 has gained the support of three prominent national eye care organizations. The Canadian Association of Optometrists, the Opticians Association of Canada and the Canadian Ophthalmological Society are important stakeholders in any discussion on eye care.

Furthermore, my office has been contacted by numerous provincial bodies and even eye care organizations from across the United States and Europe, each of whom are extremely supportive of the work we are doing here today with regard to helping to make Bill C-313 law.

I believe the work of these professional eye care stakeholders in Bill C-313 would finally address the lack of regulatory oversight on what are called “non-corrective cosmetic contact lenses”.

Due to the importance of Bill C-313 toward consumer protection and the overall health and well-being of Canadians, I was able to obtain the full support of all the opposition parties and their health critics when my bill was first introduced. Today I thank them for that same support to send my bill to committee for further study.

I am also honoured to have the support of the Minister of Health and I thank her for her support on the bill.

Asked by constituents and others why I would bring Bill C-313 forward, I have explained that my objective was to fully address the concerns held by myself, other parliamentarians and thousands of eye care professionals across Canada about the impact that cosmetic contact lenses was having on the health of our youth and those unaware of the potential side effects of using such a consumer product.

For example, in the past few months, since Bill C-313 was introduced in the House, millions of cosmetic contact lenses have been recalled across North America. These lenses were sold by various companies over the Internet with little to no regard for the safety of the customer purchasing these products, which is exactly what this legislation intends to prevent.

Severe complications did occur for some of the consumers who purchased these tainted lenses, which led to the recent recall in question. Such complications are likely to occur due to unsafe handling and wearing an improperly fitted lens in one's eye. These issues are also known to increase with the lack of professional oversight when these products are initially obtained by the consumer. A list of complications would include the following: conjunctivitis, corneal abrasions, giant papillary conjunctivitis, microbial keratitis and other forms of bacterial, allergic and microbial infections as specified by the eye care industry.

Already we know that these complications all occur with prescribed corrective lenses, which is exactly why Health Canada regulates the use of those products through opticians and regulatory bodies.

Before I finish, I will share with members a quote from Dr. Lillian Linton, president of the Canadian Association of Optometrists. After Bill C-313 was introduced, she stated:

This is about people’s eyesight…. There are daily news stories from around the world about the complications that can arise due to ill-fitting cosmetic lenses or improper use and handling. It is an important vision health issue and the optometrists, opticians and ophthalmologists of Canada are asking for unanimous support from the House, Senate and Health Canada to adopt this amendment and enact it with haste.

The time has come for us as parliamentarians to join together to support Bill C-313 so we can ensure that the required regulatory changes are made. In doing so, we, as MPs, can ensure that the eye health of thousands of Canadians remains adequately protected.

With this in mind, I call on all parliamentarians in the House today to stand in support of Bill C-313.